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A B S T R A C T 
C. citratus, known as zacate de limón (lemongrass), is commonly used in Costa Rica for the treatment of "kidney diseases." 
Therefore, the activity as renal protector of an aqueous extract of this plant was evaluated after oral administration, in a model of 
acute kidney injury (AKI) in female Wistar rats. For this, an aqueous extract was characterized by thin layer chromatography and 
qualitative phytochemical tests. An AKI model induced by potassium chromate in female Wistar rats was carried out. The serum 
concentration of creatinine, sodium, potassium and glucose were determined, as well as the concentrations of creatinine, sodium, 
potassium, glucose and proteins in urine, together with the urinary flow determination. A histopathological analysis of the 
subjects’ kidneys was performed, and the presence of kidney damage was identified. The characterization of the extract by thin 
layer chromatography, and ferric chloride, Shinoda and Wilson tests gave negative results for phenols, tannins and flavonoids. No 
positive changes were observed in renal function markers in urine. No histopathological evidence of nephroprotective activity of 
the aqueous extract of C. citratus was found. It is concluded that the aqueous extract of C. citratus obtained by infusion does not 
possess nephroprotective activity at a dose of 150 mg/kg evaluated by the AKI in female Wistar rats. 
Keywords: Acute renal failure, potassium chromate, lemongrass, phytochemistry, nephroprotection, Wistar rats. 
 
 A R T I C L E I N F O: Received 18 Sept. 2019;    Review Completed 19 Nov. 2019;     Accepted 20 Nov. 2019;           Available online 15 Dec. 2019 
 Cite this article as:  
Apú Leitón N, Fallas Ramírez JM, Orozco Aguilar J, Rodríguez Arrieta JA, Mora Román JJ, Absence of Renal Protection of an 
Aqueous Extract of Lemongrass (Cymbopogon citratus) Cultivated in Costa Rica, Using a Model of Acute Renal Failure in 
Wistar RatsAsian Journal of Pharmaceutical Research and Development. 2019; 7(6):11-19 
DOI: http://dx.doi.org/10.22270/ajprd.v7i6.617       
*Address for Correspondence:   
Apú Leitón Navilla, Pharmacology, Toxicology, and Pharmacodependence Department, Pharmacy Faculty, Universidad de Costa Rica, San José, Costa 
Rica 
 
 
INTRODUCTION 
KI is a clinical syndrome that occurs through a rapid 
decrease in glomerular filtration, this over the course 
of hours or days. It is usually accompanied by an 
increase in the serum concentration of creatine, the 
accumulation of metabolic acids, an increase in the 
concentration of phosphate and potassium, and a decrease in 
the excretion of urine1-4. In recent years, studies have been 
conducted in the United States, where an increase in the 
incidence rate of the AKI has been seen. An increase of 61 to 
288 cases per 100,000 inhabitants between 1988 and 2002 
has been reported5. In addition, in Scotland in 2003 there was 
a report of 1,811 cases per million inhabitants6. 
A 
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At present there is no specific pharmacological treatment for 
this disease, so some sectors of the population have tried to 
seek new therapeutic alternatives against this disease. An 
example of this is the use of medicinal plants whose use over 
the years has been frequent in Costa Rica, since it has long 
been the doctor's only resource for treating a condition7. In 
this country, there is an extensive amount of plants used in 
medicine; thanks to the great biodiversity it has. However, 
the scientific literature that supports these uses is small8, one 
of which is C. citratus. Although some authors suggest that 
C. citratus has nephroprotective properties, others indicate 
that it is nephrotoxic and acts in a similar way to loop 
diuretics9-11. 
C. citratus, commonly known as zacate de limón (in Costa 
Rica), is native to southwestern Asia. Currently, it can be 
found in different areas, covering both neo and intertropical 
regions. It easily develops in hot and humid areas, with 
rainfall of 250 to 330 cm per year and a temperature that 
ranges between 20 and 30 °C12, 13. Its growth occurs in dense 
clusters that can reach a height of 1.8 m and a width of 
approximately 1.2 m14. It has traditionally been used in the 
preparation of food, due to its flavor, in the perfumery and 
cosmetics industry (for its lemon essence), and in traditional 
medicine, for the various properties that have been attributed 
to it12, 15. Its use as a drug is due to the effects it produces, 
thanks to its secondary bioactive components which vary 
according to the geographical area of origin, the age of the 
plant used, the extraction method, the time of collection and 
the section of the plant employed. Some of the main 
compounds found are tannins, saponins, flavonoids, alkaline 
phenols and anthraquinones9. 
Therefore, the objective of the present investigation was to 
evaluate the activity as renal protector of an aqueous extract 
of C. citratus after its administration in an AKI model in 
female Wistar rats. 
MATERIALS AND METHODS 
Reagents 
Potassium chromate, Bradford's reagent, and serum 
creatinine, glucose, and bovine albumin standards were 
Sigma-Aldrich® brand. The kits for glucose and creatinine 
were Randox®. The reagents for the phytochemical analysis 
were polyphenone 60 and caffeic acid from Sigma-Aldrich® 
and quercetin dihydrate from Fluka®. 
Vegetal material 
Leaves of C. citratus were collected at the Escuela de 
Agronomía de la Región Tropical Húmeda (EARTH 
University), located in Mercedes, Limón (10°13'09"N 
83°35'33"W). The collected samples were determined by the 
botanist Dr. Carlos Morales of the Universidad de Costa 
Rica (UCR) and were deposited in the herbarium of the 
School of Biology of the UCR, following the procedural 
standards of the UCR Commission on Biodiversity. 
Aqueous extract preparation and characterization 
It was carried out in the Laboratorio de Fitofarmacología y 
Tecnología Farmacéutica y Cosmética (LAFITEC) of the 
Pharmacy Faculty of the UCR. The extract was prepared by 
infusion. For this, 60 g of dried and ground leaves were taken 
with a standard WILEY MILL mill No. 0.3, and 500 ml of 
boiling water were added. Subsequently, the mixture was 
allowed to stand in a glass container with a lid for 30 
minutes. After this period, the infusion was decanted, and the 
volume was reduced by a Büchi R-134 rotavapor. Finally, it 
was lyophilized using the LAZONON® FreeZone freeze 
dryer. 
The characterization of the aqueous extract was carried out 
by thin-layer chromatography and supplemented by 
phytochemical tests to evaluate the presence of tannins, 
flavonoids and phenols16. Silica gel plates were used and as 
mobile phase a solution of toluene-ethyl acetate-formic acid 
(5:4:1)17. The development was made with the naked eye and 
with ultraviolet light (256 nm) for the flavonoids. For this, 
FeCl3 10% was used for tannins, AlCl3 1% in ethanol for 
flavonoids and sulfuric acid 5% in ethanol together with 
vanillin 1% in ethanol for phenols18, 19. The standards used 
were polyphenone 60 from green tea for phenols, caffeic acid 
for phenols and quercetin dihydrate for flavonoids. 
The phytochemical test carried out included the Shinoda and 
Wilson tests for flavonoids and the FeCl3 test for phenolic 
compounds16, 20. The Shinoda test was done by adding a 
metallic magnesium chip and 5 drops of concentrated HCl to 
2 ml of aqueous extract. In addition, distilled water was used 
as blank and quercetin as reference standard16. 
For the Wilson test, 1 ml of aqueous extract was mixed with 
2 ml of Wilson reagent (boric acid and citric acid, both 5%, 
in acetone). Distilled water was used as blank and quercetin 
as reference standard20. 
In relation to the ferric chloride test, 2 ml of aqueous extract 
was mixed with 5 drops of FeCl3 10%. Distilled water was 
used as blank and quercetin as reference standard16. 
Biologic material 
Wistar Hannover adult female rats (HsdBriHan: WIST) of 
200 ± 14 g of body weight, reared in the Laboratorio de 
Ensayos Biológicos (LEBi) of the UCR, were used. The trial 
was approved by the Comité Institucional para el Cuidado y 
Uso de los Animales (CICUA) on the official letter 018-16. 
The animals’ handling and care was done following the 
procedures of the Guía para el cuido y uso de animales de 
laboratorio of the UCR, which develops the provisions 
established in the law 7451 (Animal Welfare). They were 
maintained in the conditions of the bioterium (constant 
temperature of 22 to 24 °C, relative humidity of 60 to 70%, 
and light and dark cycles of 12 hours) for adaptation during 7 
days before the biological test, with access to water 
(Members selection®) and food (Aguilar & Solís®) ad 
libitum. 
Lyophilized dose determination 
The administered dose to each animal corresponded to 150 
mg of lyophilisate per kg of rat weight per oral route. A 
higher dose was used in comparison to that employed in 
previous studies21 to observe the effect of the plant, 
considering the maximum doses allowed by the Programa 
Iberoamericano de Ciencia y Tecnología para el 
Desarrollo22. 
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Experimental design 
After the adaptation period, the rats were weighed and 
distributed randomly in 4 groups of 5 rats each. A first group 
called control without AKI (group 1, negative control), a 
second group to which the AKI was induced (group 2, 
positive control), a third group to which the AKI was 
induced and subsequently received a daily dose during 4 
days of the extract (group 3, AKI + Tx), and a fourth group 
that was treated with the extract 3 hours before the induction 
of the AKI and subsequently received a daily dose for 4 more 
days of the same extract (group 4, AKI + PTx). 
The biological test lasted 4 days, during which the animals 
had access to food and water ad libitum. On day one, animals 
from the control group without AKI received a dose of 250 
μl of sterile water for injection subcutaneously (vehicle). The 
other animals (groups 2 to 4) received a single dose of 20 
mg/kg of potassium chromate from Sigma-Aldrich® in 
Baxter® physiological saline solution for injection, 
subcutaneously to induce AKI23. The animals of group 4 
received 3 hours before the induction of the AKI, a dose of 
150 mg/kg orally, of the lyophilizate solution of the extract. 
On days 1, 2, 3, and 4 of the experiment, the animals of the 
control group without AKI and the AKI group received a 
dose of 2 μl/g of water weight (vehicle) orally, while those of 
groups 3 and 4 received a dose of 150 mg/kg (equivalent to 2 
μl/g of weight) of the lyophilized solution of the extract. On 
day 5 and after the administration of the vehicle or the 
extract last dose, the animals were placed in metabolic cages 
for a period of 8 hours, to collect urine from that period. This 
was separated into fractions of 750 μl and frozen at -70 °C 
until analysis. 
Once this collection period had elapsed, the total blood of the 
animals was extracted using the decapitation technique. The 
blood was centrifuged at 3000 rpm using a Hettich® 
Universal 320/320R centrifuge for 10 minutes to separate the 
serum, which was collected in 500 μl fractions and frozen at 
-80 °C until analysis. 
Renal protection evaluation 
The following markers of renal functioning were determined 
in the four groups of animals: creatinine, sodium, potassium 
and serum glucose concentrations, creatinine, sodium, 
potassium, glucose and protein levels in urine, and urine flow 
(UF). Subsequently, glomerular filtrate rate (GFR), as well as 
urinary excretions of sodium (UENa), potassium (UEK) 
glucose (UGE) and protein (UPE) were calculated23. 
The concentrations of creatinine in serum and urine were 
determined colorimetrically, using the Randox® kit for the 
determination of this substance23. 
The serum and urinary concentrations of sodium and 
potassium were measured at the Departamento de Análisis 
Clínico (DAC) of the Faculty of Microbiology of the UCR 
with the help of the Roche® AVL 9180 electrolyte analyzer. 
Subsequently, the electrolyte balance was determined by the 
calculation of the purification, the urinary excretion, the 
fractional excretion and the filtered load of both sodium and 
potassium23, 24. 
The glucose concentration in serum and urine was measured 
by the ultraviolet GLUC-HK method with the Randox® kit 
for glucose determination25, 26. Finally, the total proteins in 
urine were measured following the Bradford method27. 
Histopathological analysis of the kidneys 
After the application of euthanasia, both kidneys were 
extracted to all experimental animals. They were fixed in 
formalin 10% in the presence of a phosphate buffer and 
embedded in paraffin to obtain thin sections at 4 μm 
thickness, with transversal and longitudinal sections. 
Subsequently, they were stained with hematoxylin-eosin 
following conventional protocols28. The histopathological 
protocols were carried out in the CIEMic of the UCR. For 
each kidney, evidence of kidney damage induced by 
potassium chromate was identified. The photographs were 
obtained in a Zeiss AxioLab microscope adapted with a 5-
megapixel camera and processed by Zen lite software from 
Zeiss®. 
Statistical analysis 
The results were expressed as the mean along with the 
standard error of the mean. Parametric tests were carried out 
by using the IBM® SPSS® Statistics 23 program. The 
statistical difference between groups was calculated by a 
one-way ANOVA and the comparison of means between 
groups was done by the Tukey post-hoc method, with 95% 
significance level significance. Both analyzes were 
performed in the GraphPad Prism 6 program. 
RESULTS AND DISCUSSION 
The AKI induction by potassium chromate causes kidney 
damage at the tubular level, since in the chromium 
metabolization, reactive species that interact with membrane 
and intracellular proteins are produced in the tubules, altering 
the reabsorption and the secretion processes23. In this way, 
the process of tubular necrosis is induced. In Wistar rats, as 
in humans, the toxicity of chromium is determined by its 
high renal excretion, its oxidation state (the reduction of Cr+6 
to Cr+3 is responsible for the production of reactive species) 
and the solubility of its compounds (Cr+6 is easier to absorb 
compared to Cr+3)29-32. 
Characterization of the aqueous extract by 
phytochemical screening 
An aqueous extract of C. citratus was obtained by infusion, 
with a recovery percentage of 7.51%. 
In the characterization carried out, it was found that when the 
chromatographic plate was revealed with AlCl3, the result 
was negative for flavonoids with respect to the quercetin 
standard used. As a complement, with FeCl3 as a 
visualization reagent, the presence for tannins was not found 
in comparison to the polyphenone 60 from green tea 
standard. Likewise, when using vanillin and sulfuric acid to 
reveal phenols, the test was also negative when the 
comparison was made with respect to the caffeic acid 
standard. These results were also reflected in the 
phytochemical tests of ferric chloride, Shinoda and Wilson, 
as they were negative for the three cases. This coincides with 
previous studies where flavonoids and tannins have not been 
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found and a small amount of phenols has been observed in 
the aqueous extract33, 34. 
Variation of renal function and kidney damage markers 
Regarding the model used, previous studies have shown that 
a single dose of potassium chromate is sufficient to generate 
physiological alterations in the subjects’ kidney, such as 
changes in GFR and an increase in serum creatinine; which 
occur between days 3 and 5 after the induction of 
insufficiency23, 29, 31. 
In relation with the GFR, a significant decrease in creatinine 
clearance was found in the rats treated and pretreated with C. 
citratus compared to the control group without AKI after 4 
days of treatment with a dose of 150 mg/kg of aqueous 
extract of C. citratus. However, no significant differences 
were found with respect to the control group with AKI and 
neither between them, as can be seen in Figure 1A. 
The GFR by the kidney per unit of time is determined by the 
measurement of creatinine clearance, since this compound is 
freely filtered at the glomerular level and suffers very little 
tubular handling35. In the presence of kidney damage, it tends 
to decrease, because of the alteration of the filtration 
processes3, 4. In addition, consequently, the serum creatinine 
concentration tends to increase in the sick subjects, since the 
renal capacity is not available to eliminate it, accumulating in 
the blood35. 
Therefore, there is no evidence of a decrease in the renal 
damage in both the AIK + Tx and AIK + PTx groups, unlike 
that found in the literature. In Wistar rats, it was 
demonstrated that an ethanolic extract of C. citratus did not 
generate significant alteration in the serum concentration of 
creatinine11. As a complement, in Sprague Dawley, rats no 
significant change was obtained after the chronic 
administration of an infusion of this plant36, whereas in male 
albino rats, previously treated for six days with an aqueous 
extract of C. citratus before the AIK induction with cisplatin, 
significant differences were observed regarding the control 
with AIK in the serum creatinine values, which indicates a 
nephroprotective effect of the aqueous extract37. In contrast, 
there is evidence of a decrease in glomerular filtration in 
humans after the administration of a chronic treatment of an 
infusion of C. citratus38, in agreement with the results 
obtained. 
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Figure 1. Variation of creatinine, glucose and protein clearance in female Wistar rats treated and pre-treated with aqueous extract of C. citratus. A. The AKI, 
AKI + Tx, and AKI + PTx groups showed a decrease in creatinine clearance compared to the control group. B. AKI and AKI + PTx groups showed a 
significant increase in urinary glucose excretion, compared to the control group, while there was an upward trend for the AKI + Tx group. C. The AKI, AKI + 
Tx, and AKI + PTx groups showed a significant increase in urinary protein excretion with respect to the control group. The average of the values obtained for 
each treatment is shown along with the respective standard mean error. The results were analyzed by one-way ANOVA **** p <0.0001, *** p <0.001, ** p 
<0.01, * p <0.05, five rats per group, except in the AKI + Ptx group that was worked with 4 subjects. 
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On the other hand, a parameter frequently used to assess 
renal failure is the glucose reabsorption in the kidneys, given 
by active glucose transporters located in the proximal 
tubule39. Glucose is reabsorbed 100% under normal 
conditions, so it is not usually found in urine unless there is 
damage at the level of this tubule40. The determination of the 
urinary glucose concentration and its excretion are markers 
of the nephron reabsorption function41. 
Our results showed that the glucose excretion (Figure 1B) 
was significantly increased in the AKI and AKI + Ptx groups 
compared to the control group without AKI, which presented 
excretions very close to 0. In the AKI + Tx, there was a 
tendency to increase in relation to negative control. Also, 
among the groups with treatment and pre-treatment with C. 
citratus, there were no significant differences. These 
increases are clear evidence of lesions in the proximal tubule. 
It has been shown that in female Wistar rats, when inducing 
AIK by dichromate, the concentration of urinary glucose 
undergoes a constant increase41, 42. Since there were no 
differences in urine concentration and glucose excretion in 
the treatment and pre-treatment groups with C. citratus and 
the AIK group, it is not possible to consider that the aqueous 
extract of this plant possesses nephroprotective activity. 
Otherwise, a significant decrease in these values with respect 
to the positive control would have been expected, as has been 
demonstrated previously with other extracts in the animal 
model used30, 43. 
Finally, the presence of proteins in urine was evaluated, since 
low molecular weight proteins degradation and absorption 
occurs mainly in the proximal tubule. The low molecular 
weight proteins absorption is given by peptidases of the 
brush border membrane present in this tubule. As a 
complement, those of high molecular weight are absorbed by 
endocytosis, taken to the proximal tubule and introduced in 
lysosomes for their degradation44. The induction of AIK by 
chromate causes damage to the brush border membrane, due 
to the free radicals’ action, losing the capacity of protein 
resorption32, 45. For this reason, it is common to find proteins 
in the glomerular filtrate (proteinuria), and its presence has 
been commonly used as a marker of AIK. In addition, it 
occurs during the first 4 days after induction with potassium 
chromate41, 42. 
Significant increases in urinary excretion were found in the 
groups treated with the aqueous extract compared to the 
control group without AIK and no significant differences 
were found with respect to the positive control. This 
information is shown in Figure 1C.  
Consequently, this parameter also shows the non-existence 
of nephroprotection of the aqueous extract of C. citratus. The 
expectation was to find a significant decrease in this 
parameter because in the animal model of AIK used, the 
nephroprotective activity is exhibited by a decrease in 
urinary protein excretion23, 30, 41. These results differ from 
what was found in previous studies; for example, in rabbits 
with AIK induced by gentamicin, it was observed as this 
plant caused a significant reduction in urinary protein 
excretion10 and in Wistar rats, it was reported that an 
ethanolic extract of C. citratus did not significantly alter the 
protein excretion with respect to the group without AIK11. 
Regarding the water balance, the findings are summarized in 
Table 1. The tubular handling of sodium and potassium 
electrolytes is done throughout the nephron. However, at 
proximal tubule level, its reabsorption is greater42. The 
proximal tubule is characterized by having a layer of cells 
that has microvilli at the luminal border, increasing the 
surface area of salt, water and other molecules reabsorption, 
and generating high permeability for electrolytes such as 
sodium and potassium46-48. Sodium reabsorption is carried 
out by active transport through the sodium-potassium pump 
powered by ATP, through a positive gradient for potassium 
reabsorption by diffusion49, 50. It has been indicated that the 
induction of AIK with chromate, by acting on the proximal 
tubule, decreases the reabsorption processes of sodium and 
potassium, altering the electrolyte balance of the individual. 
Therefore, it seeks to compensate the balance by reducing the 
clearance of these ions23, 41, 42. 
 
Table 1: Variation of the electrolyte balance in female Wistar rats treated and pre-treated with aqueous extract of C. citratus 
Group Sodium 
depuration  
(µL/min) 
Potassium 
depuration 
(µL/min) 
Urinary 
sodium 
excretion 
(µmol/min) 
Urinary 
potassium 
excretion 
(µmol/min) 
Fractional 
sodium 
excretion  
Fractional 
potassium 
excretion  
Filtered 
sodium load  
(µmol/min) 
Filtered 
potassium 
load 
(µmol/min) 
Control 4.096 ± 0.325 186.5 ± 14.8 
0.6185 ± 
0.0490 
1.119 ± 0.089 2.922 ± 0.164 133.1 ± 7.4 
0.0214 ± 
0.0019 
0.00085 ± 
0.00007 
AKI 1.007 ± 0.164 169.4 ± 27.7 
0.1551 ± 
0.0253 
0.9996 ± 
0.1631 
1.528 ± 0.200 257.1 ± 33.7 
0.0102 ± 
0.0014 
0.00038 ± 
0.00005 
AKI + Tx 3.672 ± 0.845 153.7 ± 35.4 
0.5104 ± 
0.1175 
0.8456 ± 
0.1946 
6.706 ± 1.094 280.8 ± 45.8 
0.0074 ± 
0.0012 
0.00030 ± 
0.00005 
AKI + 
Ptx 
2.007 ± 0.211 139.5 ± 14.6 
0.2790 ± 
0.0293 
0.8370 ± 
0.0877 
3.372 ± 0.428 234.3 ± 29.7 
0.0088 ± 
0.0010 
0.00037 ± 
0.00005 
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Our results show that both sodium clearance and urinary 
sodium excretion in the AIK + Ptx group decrease 
significantly compared to the control group without AIK. In 
contrast, in the AIK + Tx group there was no significant 
decrease in sodium clearance and excretion in contrast to the 
negative control, but there was a significant decrease in 
relation to the positive one. Therefore, there is no evidence of 
nephroprotection by the aqueous extract of C. citratus, 
although there could be a regenerative effect on the part of 
the latter in the sodium channels in the proximal tubule when 
treatment is administered after the induction of AIK.  
In addition, no differences were found in the potassium 
purification and excretion between the groups. However, 
there was a decrease in the groups with AIK compared to the 
group without AIK. This is consistent with a previous study 
where there were no significant differences with respect to 
the control group on the fourth day after induction in the 
model used, despite a significant decrease on days 3 and 542. 
Another parameter determined was the fractional excretion, 
defined as the percentage of filtered ion excreted in the urine. 
It has been used to estimate the renal management of cations 
and as a renal marker of AIK, related to its sensitivity23, 41. 
Significant differences were observed in the fractional 
sodium excretion in the AIK + Tx group with respect to the 
other groups, which showed no differences between them, 
despite previous studies showing that in the presence of AIK, 
fractional excretion of sodium is increased43, 49. In addition, 
in the fractional potassium excretion, the same result was 
obtained as in sodium. Only the AIK + Tx group presented 
significant differences with respect to the control group 
without ARI. Therefore, the AIK + Tx group exhibits 
evidence of renal damage in contrast to the other groups that 
show no alteration in the fractional excretion of sodium and 
potassium. 
In addition, the filtered loads of sodium and potassium of the 
AIK + Tx and AIK + PTx groups presented a significant 
decrease compared to the control group without AIK and did 
not present differences in contrast to the positive control. 
Therefore, there is no evidence of nephroprotective activity 
by the aqueous extract of C. citratus, since a smaller number 
of electrolytes is being filtered to compensate for kidney 
damage. 
Renal histopathological analysis 
The results of the histopathological analysis are shown in 
Figure 2. The AIK induction at the histological level causes 
characteristic alterations in renal toxicity such as the 
presence of pyknotic nuclei and hyaline deposits, as well as 
the microvilli loss in the proximal tubule30, 45. AIK generates 
acute tubular necrosis characterized by cell death of the 
tubular epithelium and tubular functions alteration52. 
In the kidneys’ histopathological analysis of the experimental 
subjects, pyknotic nuclei were observed in the cells of the 
groups treated with the aqueous extract and the group with 
AIK, unlike the cells of the control group. This is evidence of 
the damage caused by chromate in renal tissue, as reported in 
previous studies in Wistar rats53, 54. In addition, no 
improvement was observed in the groups treated with respect 
to the positive control, so histologically nephroprotection 
was not found. 
In healthy subjects, as in the group without AIK, the proteins 
are extracted from the circulation by glomerular filtration and 
then absorbed by endocytosis towards the proximal tubule. 
There, they are phagocytosed, the amino acids hydrolysis is 
produced, and then, they are returned to the circulation44, 55. 
However, when there is a pathology in the kidney, these 
mechanisms are altered, causing the accumulation of amino 
acid residues in the tubular cytoplasm, known as hyaline 
depositions. They are characterized by having a variable size, 
a rounded shape and large amounts of eosinophils when 
stained with hematoxylin and eosin55. Previously, it has been 
shown that the kidney damage induction with chromate 
generates the development of hyaline depositions in the 
kidney tissue of Wistar rats30, 54. The histopathological results 
showed abundance of these depositions in the renal tissue of 
the subjects with treatment and pre-treatment with aqueous 
extract of C. citratus with respect to those of the negative 
control. 
Regarding the research developed, no evidence of 
nephroprotection was found in the groups treated with C. 
citratus when comparing this parameter to subjects with AIK 
without treatment. 
Another observed portion was the proximal tubule 
epithelium. It consists of a highly polarized cuboidal cell 
layer, except for the brush border membrane. This membrane 
is a consequence of the cells luminal side specialization, 
resulting in a microvilli dense population44. These microvilli 
are structures composed of actin that facilitate the exchange 
of substances between the extracellular and the intracellular 
medium, since they increase the cells surface area56, 57. 
Previous studies have reported that kidney damage caused by 
chromium causes microvilli loss in the proximal tubule45. 
Our results revealed the microvilli loss in subjects who 
received treatment and pre-treatment with the aqueous 
extract in contrast to that observed in the control group 
without AIK. In addition, no differences were found with 
respect to the positive control that evidences that the extract 
used of C. citratus possesses nephroprotective activity. All 
the above contradicts the results obtained in rabbits treated 
with an aqueous extract of the same plant material, where no 
kidney damage was observed10. 
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Figure 2. Histopathological findings in kidneys extracted in an AKI model induced by potassium chromate in female Wistar rats. A. Cross sections of 
the kidney of the control group without AKI showing renal corpuscles and tubules without alteration. B. Presence of microvilli (a) in the healthy tissue of rats 
in the control group without AKI. C. E. G. Cross sections of the kidney of the AKI, AKI + Tx and AKI + Ptx groups, respectively, showing hyaline deposits 
(a) and loss of microvilli (b). D. F. H. Presence of pyknotic nuclei (a) and loss of microvilli in the renal tissue (b) of the AKI, AKI + Tx and AKI + Ptx groups, 
respectively. The histopathological findings indicate that the kidney of the group without AKI is in a healthy physiological state, and the groups to which the 
AKI was induced present evidence of acute renal damage. 
CONCLUSIONS 
We sought to evaluate the activity as renal protector of an 
aqueous extract of C. citratus after its administration in an 
AKI model in female Wistar rats. The aqueous extract 
obtained by infusion did not contain phenols, tannins or 
flavonoids detectable by thin layer chromatography, and by 
the Shinoda, Wilson, and ferric chloride tests. In addition, the 
administration of a pre-treatment and a treatment with an 
aqueous extract of C. citratus did not cause significant 
positive differences in the markers of renal function and 
damage at structural level such as GFR, sodium and 
potassium clearance, urinary excretion of sodium and 
potassium, fractional excretion of sodium and potassium, 
filtered load of sodium and potassium, urinary excretion of 
glucose, and urinary excretion of proteins of the subjects 
treated with respect to those of the AKI group without 
treatment. On the other hand, the histopathological analysis 
of the kidneys of the experimental subjects showed the 
presence of pyknotic nuclei, hyaline deposits and microvilli 
loss both in the renal tissue of the treated groups and in the 
AKI group without treatment, unlike the control group 
without AKI where those changes were not observed. For all 
the above, the results obtained show that there is no evidence 
that the aqueous extract of C. citratus cultivated in Costa 
Rica has nephroprotective activity when using a model of 
AKI induced by potassium chromate in female Wistar rats 
with the administered dose. 
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